221 related articles for article (PubMed ID: 35435948)
21. Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.
Issa TZ; Lee Y; Mazmudar AS; Padovano R; Lambrechts MJ; Canseco JA; Hilibrand AS; Vaccaro AR; Kepler CK; Schroeder GD
J Am Acad Orthop Surg; 2023 Jul; 31(13):677-686. PubMed ID: 37015104
[TBL] [Abstract][Full Text] [Related]
22. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
Horný M; Shafer PR; Dusetzina SB
JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
[TBL] [Abstract][Full Text] [Related]
23. Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.
Jiang JX; Polsky D; Littlejohn J; Wang Y; Zare H; Bai G
J Gen Intern Med; 2022 Nov; 37(14):3577-3584. PubMed ID: 34902095
[TBL] [Abstract][Full Text] [Related]
24. Compliance With Federal Price Transparency Rules and Cost Estimation at United States Hospitals With Neurosurgical Training Programs.
Giantini-Larsen A; Pandey A; Abou-Mrad Z; Tata N; Barzilai O; Bilsky M; Newman WC
Neurosurgery; 2024 Feb; ():. PubMed ID: 38345364
[TBL] [Abstract][Full Text] [Related]
25. Increasing Divergence in Drug Prices Between the United States and Germany After Implementation of Comparative Effectiveness Analysis and Collective Price Negotiations.
Berkemeier F; Whaley C; Robinson JC
J Manag Care Spec Pharm; 2019 Dec; 25(12):1310-1317. PubMed ID: 31778624
[TBL] [Abstract][Full Text] [Related]
26. Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
Clemans-Cope L; Epstein M; Banthin J; Kesselheim AS; Hwang TJ
JAMA Health Forum; 2023 Jan; 4(1):e225012. PubMed ID: 36637815
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.
Agarwal A; Dayal A; Kircher SM; Chen RC; Royce TJ
JAMA Oncol; 2020 Mar; 6(3):409-412. PubMed ID: 31944219
[TBL] [Abstract][Full Text] [Related]
28. Hospital Markup in Head and Neck Cancer Surgery in the US.
Miller JR; Frick KD; Gourin CG
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1147-1155. PubMed ID: 36301556
[TBL] [Abstract][Full Text] [Related]
29. Association of Commercial-to-Medicare Relative Prices With Health System Financial Performance.
Blavin F; Kane N; Berenson R; Blanchfield B; Zuckerman S
JAMA Health Forum; 2023 Feb; 4(2):e225444. PubMed ID: 36763368
[TBL] [Abstract][Full Text] [Related]
30. Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures.
Zhang Y; Cerullo M; Esposito A; Golla V
J Natl Compr Canc Netw; 2022 Nov; 20(11):1215-1222.e1. PubMed ID: 36351331
[TBL] [Abstract][Full Text] [Related]
31. Negotiated Rates for Surgical Cancer Care in the Era of Price Transparency-Prices Reflect Market Competition.
Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
Ann Surg; 2024 Mar; 279(3):385-391. PubMed ID: 37678179
[TBL] [Abstract][Full Text] [Related]
32. Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.
Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
JAMA Surg; 2023 Feb; 158(2):152-160. PubMed ID: 36515928
[TBL] [Abstract][Full Text] [Related]
33. Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022.
Rome BN; Nagar S; Egilman AC; Wang J; Feldman WB; Kesselheim AS
JAMA Health Forum; 2023 Jan; 4(1):e225218. PubMed ID: 36705916
[TBL] [Abstract][Full Text] [Related]
34. Health Care Price Transparency in Ophthalmology.
Berkowitz ST; Siktberg J; Hamdan SA; Triana AJ; Patel SN
JAMA Ophthalmol; 2021 Nov; 139(11):1210-1216. PubMed ID: 34617970
[TBL] [Abstract][Full Text] [Related]
35. Variation in the Price of Head and Neck Surgical Oncology Procedures.
Wu MP; Xiao R; Rathi VK; Sethi RKV
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):536-539. PubMed ID: 35671092
[TBL] [Abstract][Full Text] [Related]
36. There Is Wide Variation in Platelet-rich Plasma Injection Pricing: A United States Nationwide Study of Top Orthopaedic Hospitals.
Tiao J; Wang K; Herrera M; Ren R; Rosenberg AM; Cassie R; Poeran J
Clin Orthop Relat Res; 2024 Apr; 482(4):675-684. PubMed ID: 37815436
[TBL] [Abstract][Full Text] [Related]
37. Variation in hospital inpatient prices across small geographic areas.
Maeda JL; Mosher Henke R; Marder WD; Karaca Z; Friedman BS; Wong HS
Am J Manag Care; 2014; 20(11):907-16. PubMed ID: 25495111
[TBL] [Abstract][Full Text] [Related]
38. Uncovering the interhospital price variations for vasectomies in the United States.
Mortach S; Sellke N; Rhodes S; Sun HH; Tay K; Abou Ghayda R; Loeb A; Thirumavalavan N
Int J Impot Res; 2024 Feb; ():. PubMed ID: 38383856
[TBL] [Abstract][Full Text] [Related]
39. Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.
Dickson S; Reynolds I
JAMA Netw Open; 2019 Jul; 2(7):e196541. PubMed ID: 31276176
[TBL] [Abstract][Full Text] [Related]
40. Hospital Prices For Commercial Plans Are Twice Those For Medicare Advantage Plans When Negotiated By The Same Insurer.
Meiselbach MK; Wang Y; Xu J; Bai G; Anderson GF
Health Aff (Millwood); 2023 Aug; 42(8):1110-1118. PubMed ID: 37549324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
